PubMed

Oral metoclopramide and cisplatin chemotherapy.

Garnick MB.

Ann Intern Med. 1983 Jul;99(1):127. No abstract available. PMID: 6683089 [PubMed - indexed for MEDLINE]Related articles

Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.

Gebbia V, Testa A, Valenza R, Cannata G, Tirrito ML, Gebbia N.

Cancer. 1995 Nov 15;76(10):1821-8.PMID: 8625054 [PubMed - indexed for MEDLINE]Related articles

Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.

Navari RM, Province WS, Perrine GM, Kilgore JR.

Cancer. 1993 Jul 15;72(2):583-6.PMID: 8319191 [PubMed - indexed for MEDLINE]Related articles

Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.

Strum SB, McDermed JE, Opfell RW, Riech LP.

JAMA. 1982 May 21;247(19):2683-6.PMID: 7043002 [PubMed - indexed for MEDLINE]Related articles

Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.

Heron JF, Goedhals L, Jordaan JP, Cunningham J, Cedar E.

Ann Oncol. 1994 Sep;5(7):579-4.PMID: 7993831 [PubMed - indexed for MEDLINE]Related articles

Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.

Malik I, Moid I, Khan Z, Hussain M.

Am J Clin Oncol. 1999 Apr;22(2):126-30.PMID: 10199444 [PubMed - indexed for MEDLINE]Related articles

A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.

Chevallier B, Cappelaere P, Splinter T, Fabbro M, Wendling JL, Cals L, Catimel G, Giovannini M, Khayat D, Bastit P, Claverie N.

Support Care Cancer. 1997 Jan;5(1):22-30.PMID: 9010986 [PubMed - indexed for MEDLINE]Related articles

Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.

Lee CW, Suh CW, Lee JS, Lee KH, Cho GY, Kim SW, Kim SH.

J Korean Med Sci. 1994 Oct;9(5):369-75.PMID: 7702784 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.

Saito H, Shimokata K, Yamori S, Kajita M, Niimi T.

Am J Clin Oncol. 1994 Oct;17(5):422-6.PMID: 8092115 [PubMed - indexed for MEDLINE]Related articles

High dose metoclopramide as an antiemetic for patients receiving chemotherapy with cis-platinum.

Daniels M, Belt RJ.

Oncol Nurs Forum. 1982 Summer;9(3):20-2. No abstract available. PMID: 6921788 [PubMed - indexed for MEDLINE]Related articles

Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.

Cleri LB, Kris MG, Tyson LB, Pisters KM, Clark RA, Gralla RJ.

Cancer. 1995 Sep 1;76(5):774-8.PMID: 8625179 [PubMed - indexed for MEDLINE]Related articles

Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.

Roila F.

Oncology. 1993 May-Jun;50(3):163-7.PMID: 8459986 [PubMed - indexed for MEDLINE]Related articles

Effective control of cisplatin induced emesis by combination drug regimen.

Misra R, Agarwal N.

Indian J Cancer. 1994 Mar;31(1):19-22.PMID: 8063331 [PubMed - indexed for MEDLINE]Related articles

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, Braun DW Jr, Bordin LA, Braun TJ, Young CW.

N Engl J Med. 1981 Oct 15;305(16):905-9.PMID: 7024807 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.

Chang TC, Hsieh F, Lai CH, Tseng CJ, Cheng HH, Li CL, Michael BJ, Soong YK.

Cancer Chemother Pharmacol. 1996;37(3):279-85.PMID: 8529290 [PubMed - indexed for MEDLINE]Related articles

Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.

[No authors listed]

Support Care Cancer. 1994 May;2(3):167-70.PMID: 8032702 [PubMed - indexed for MEDLINE]Related articles

A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.

Ohmatsu H, Eguchi K, Shinkai T, Tamura T, Ohe Y, Nisio M, Kunikane H, Arioka H, Karato A, Nakashima H, et al.

Jpn J Cancer Res. 1994 Nov;85(11):1151-8.PMID: 7829401 [PubMed - indexed for MEDLINE]Related articles

Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone.

Heron JF.

Semin Oncol. 1995 Aug;22(4 Suppl 10):24-30. No abstract available. PMID: 7570051 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients. A controlled clinical study.

Tomirotti M, Dimaiuta M, Confalonieri M, Scanni A.

Support Care Cancer. 1994 Nov;2(6):389-92.PMID: 7858933 [PubMed - indexed for MEDLINE]Related articles

The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.

Sarcev T, Secen N, Povazan Dj, Sabo A, Popovic J, Bursac D, Kakas M, Zaric B, Milovancev A.

J BUON. 2007 Apr-Jun;12(2):245-52.PMID: 17600880 [PubMed - indexed for MEDLINE]Related articles